Literature DB >> 11454857

Side chain hydroxylations in bile acid biosynthesis catalyzed by CYP3A are markedly up-regulated in Cyp27-/- mice but not in cerebrotendinous xanthomatosis.

A Honda1, G Salen, Y Matsuzaki, A K Batta, G Xu, E Leitersdorf, G S Tint, S K Erickson, N Tanaka, S Shefer.   

Abstract

The accumulation of various 25-hydroxylated C(27)-bile alcohols in blood and their excretion in urine are characteristic features of cerebrotendinous xanthomatosis (CTX) a recessively inherited inborn error of bile acid synthesis caused by mutations in the mitochondrial sterol 27-hydroxylase (CYP27) gene. These bile alcohols may be intermediates in the alternative cholic acid side chain cleavage pathway. The present study was undertaken to identify enzymes and reactions responsible for the formation of these bile alcohols and to explain why Cyp27(-/-) mice do not show CTX-related abnormalities. Microsomal activities of 5beta-cholestane-3alpha,7alpha,12alpha-triol 25- and 26-hydroxylases, 5beta-cholestane-3alpha,7alpha,12alpha,25-tetrol 23R-, 24S-, and 27-hydroxylases and testosterone 6beta-hydroxylase, a marker enzyme for CYP3A, in Cyp27(-/-) mice livers were markedly up-regulated (5.5-, 3.5-, 6.5-, 7.5-, 2.9-, and 5.4-fold, respectively). In contrast, these enzyme activities were not increased in CTX. The activities of 5beta-cholestane-3alpha,7alpha,12alpha-triol 25- and 26-hydroxylases and 5beta-cholestane-3alpha,7alpha,12alpha,25-tetrol 23R-, 24R-, 24S-, and 27-hydroxylases were strongly correlated with the activities of testosterone 6beta-hydroxylase in control human liver microsomes from eight unrelated donors. Troleandomycin, a specific inhibitor of CYP3A, markedly suppressed these microsomal side chain hydroxylations in both mouse and human livers in a dose-dependent manner. In addition, experiments using recombinant overexpressed human CYP3A4 confirmed that these microsomal side chain hydroxylations were catalyzed by a single enzyme, CYP3A4. The results demonstrate that microsomal 25- and 26-hydroxylations of 5beta-cholestane-3alpha,7alpha,12alpha-triol and microsomal 23R-, 24R-, 24S-, and 27-hydroxylations of 5beta-cholestane-3alpha,7alpha,12alpha,25-tetrol are mainly catalyzed by CYP3A in both mice and humans. Unlike Cyp27(-/-) mice, CYP3A activity was not up-regulated despite marked accumulation of 5beta-cholestane-3alpha,7alpha,12alpha-triol in CTX.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11454857     DOI: 10.1074/jbc.M103025200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  20 in total

Review 1.  Evolution and function of the NR1I nuclear hormone receptor subfamily (VDR, PXR, and CAR) with respect to metabolism of xenobiotics and endogenous compounds.

Authors:  E J Reschly; Matthew D Krasowski
Journal:  Curr Drug Metab       Date:  2006-05       Impact factor: 3.731

2.  Cholesterol 25-hydroxylation activity of CYP3A.

Authors:  Akira Honda; Teruo Miyazaki; Tadashi Ikegami; Junichi Iwamoto; Tomomi Maeda; Takeshi Hirayama; Yoshifumi Saito; Tamio Teramoto; Yasushi Matsuzaki
Journal:  J Lipid Res       Date:  2011-05-16       Impact factor: 5.922

3.  Regulation of bile acid metabolism in mouse models with hydrophobic bile acid composition.

Authors:  Akira Honda; Teruo Miyazaki; Junichi Iwamoto; Takeshi Hirayama; Yukio Morishita; Tadakuni Monma; Hajime Ueda; Seiya Mizuno; Fumihiro Sugiyama; Satoru Takahashi; Tadashi Ikegami
Journal:  J Lipid Res       Date:  2019-10-23       Impact factor: 5.922

Review 4.  Animal models to study bile acid metabolism.

Authors:  Jianing Li; Paul A Dawson
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2018-05-18       Impact factor: 5.187

5.  Pregnane X receptor prevents hepatorenal toxicity from cholesterol metabolites.

Authors:  Junichiro Sonoda; Ling Wa Chong; Michael Downes; Grant D Barish; Sally Coulter; Christopher Liddle; Chih-Hao Lee; Ronald M Evans
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-25       Impact factor: 11.205

6.  Effect of Cyp27A1 gene dosage on atherosclerosis development in ApoE-knockout mice.

Authors:  Line Zurkinden; Curzio Solcà; Isabelle A Vögeli; Bruno Vogt; Daniel Ackermann; Sandra K Erickson; Felix J Frey; Dmitri Sviridov; Geneviève Escher
Journal:  FASEB J       Date:  2013-12-10       Impact factor: 5.191

7.  On the formation of 7-ketocholesterol from 7-dehydrocholesterol in patients with CTX and SLO.

Authors:  Ingemar Björkhem; Ulf Diczfalusy; Anita Lövgren-Sandblom; Lena Starck; Monica Jonsson; Keri Tallman; Henrik Schirmer; Lilian Bomme Ousager; Peter J Crick; Yuqin Wang; William J Griffiths; F Peter Guengerich
Journal:  J Lipid Res       Date:  2014-04-25       Impact factor: 5.922

8.  Knockout of mouse Cyp3a gene enhances synthesis of cholesterol and bile acid in the liver.

Authors:  Mari Hashimoto; Kaoru Kobayashi; Mio Watanabe; Yasuhiro Kazuki; Shoko Takehara; Asumi Inaba; Shin-Ichiro Nitta; Naoto Senda; Mitsuo Oshimura; Kan Chiba
Journal:  J Lipid Res       Date:  2013-05-24       Impact factor: 5.922

9.  Identification of an endogenous ligand that activates pregnane X receptor-mediated sterol clearance.

Authors:  Isabelle Dussault; Hye-Dong Yoo; Min Lin; Eric Wang; Ming Fan; Ashok K Batta; Gerald Salen; Sandra K Erickson; Barry M Forman
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-04       Impact factor: 11.205

10.  Mitochondrial cholesterol transport: a possible target in the management of hyperlipidemia.

Authors:  E A Hall; S Ren; P B Hylemon; K Redford; A del Castillo; G Gil; W M Pandak
Journal:  Lipids       Date:  2005-12       Impact factor: 1.880

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.